Clinical trial NCT03483597: The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis
Official title: The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Rheumatoid Arthritis
Satisfaction
Lead sponsor: Chinese SLE Treatment And Research Group
Sponsor class: OTHER
First posted: 2018-03-30
Enrollment: 1365
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Subjects come from 12 hospitals in Chinese Rheumatism Data Center.

Brief summary: A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.

Detailed description: In the last decade, China has made quick progress on treatment of rheumatoid arthritis. However, the improvement of remission rate cannot fully represent needs of patients for health. To meet health demands of patients and improve their satisfaction, an efficacy evaluation system based on the outcome report of patients should be established. A questionnaire for this research is designed and mended in view of TSQM-II treatment satisfaction questionnaire and the actual situation of RA diagnosis and treatment in China. An investigation on treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for this disease is carried out based on 120 rheumatoid immunologists and 1,200 rheumatoid arthritis patients (1:10) from Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research concludes rheumatoid specialist physicians for doctor population, and persons aged over 18 for patient population who has been confirmed as RA for 6 months above, excluding patients with Chinese reading comprehension barriers or without any RA treatment. Finally, summarize and analyze the total score of satisfaction from doctors and patients, average score of doctors and patients for various medical demands, as well as the satisfaction of patients about communication and service during medical treatment.

Eligibility criteria: Inclusion Criteria:

Doctors - registered rheumatoid specialist physicians subordinated to the 12 designated hospitals Patients - aged over 18, confirming RA for more than 6 months

Exclusion Criteria:

Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to complete the questionnaire independently), without any RA treatment

Primary outcomes:
measure: Total score of patient satisfaction
timeFrame: 1 day
Secondary outcomes:
measure: Average score of patients for various treatment demands
timeFrame: 1 day
measure: Average score of patients for long-term treatment demands
timeFrame: 1 day
measure: Average score of patients for new drug demands
timeFrame: 1 day
measure: Total score of doctor satisfaction
timeFrame: 1 day
measure: Average score of doctors for various treatment demands
timeFrame: 1 day
measure: Average score of doctors for long-term treatment demands
timeFrame: 1 day
measure: Average score of doctors for new drug demands
timeFrame: 1 day
Other outcomes:
Locations:
city: Beijing
country: China
facility: Peking Union Medical College Hospital
Study officials:
affiliation: Director of Rheumatology and Immunology Department Chinese Academy of Medical Sciences &Peking Union Medical College Hospital
name: Xiaofeng Zeng, Doctor
role: STUDY_CHAIR
References: